Reslizumab used in bronchial asthma is a monoclonal antibody against: (A) IL-2, (B) IL-3, (C) IL-4, (D) IL-5
Answer is D. Mepolizumab & Reslizumab are monoclonal antibodies against IL-5 used in bronchial asthma, which act by inhibiting recruitment of eosinophils.